WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 223

Legislative bill overview

HB 223 modifies Hawaii's pharmacy regulations, though the specific provisions are not detailed in the available legislative actions. The bill has passed initial committee review with amendments and is currently carried over to the 2026 Regular Session. The measure received support from the House Education Committee but requires further review by the Consumer Protection Committee (CPC).

Why is this important

Pharmacy regulations directly affect medication access, pricing, and healthcare delivery for Hawaii residents. Changes to licensing, operations, or service requirements can influence drug availability, consumer costs, and the relationship between pharmacists and patients across the islands.

Potential points of contention

  • The specific scope of pharmacy regulations modified is unclear from available documents, making it difficult to assess stakeholder impact without reviewing the full bill text
  • One representative voted against passage and three others were excused, suggesting potential concerns or disagreement among legislators
  • The bill's carryover to 2026 and referral to the Consumer Protection Committee indicates additional deliberation is needed before final passage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.